Kyverna Therapeutics, Inc.
KYTXNext catalyst
KYV-101
Systemic Sclerosis
Get an email about KYTX's next catalysts
Track Kyverna Therapeutics (KYTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (Phase 2 readout, Phase 3 readout).See the timeline
3 upcoming, 2 past
KYV-101 Phase 2 Est. Readout
Primary completion for KYV-101 trial (NCT06384976) in Multiple Sclerosis, Primary Progressive
SourceKYV101 Phase 2 Est. Readout (COMPARE)
Estimated primary completion for KYV101 trial (NCT06475495) in Rheumatoid Arthritis. Topline data typically follows completion by weeks to months.
SourceKYV-101 Phase 3 Est. Readout
Primary completion for KYV-101 trial (NCT06193889) in Myasthenia Gravis
SourceMarket Overview
Stock performance and key metrics
Standard lymphodepletion regimen
Lupus Nephritis
KYV-101
Systemic Sclerosis
KYV-101 anti-CD19 CAR-T cell therapy
Lupus Nephritis
Anti-CD20 mAB
Multiple Sclerosis, Primary Progressive
KYV101
Rheumatoid Arthritis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Standard lymphodepletion regimen | Phase 3 | Lupus Nephritis | - | - |
KYV-101 | Phase 3 | Systemic Sclerosis | - | - |
KYV-101 anti-CD19 CAR-T cell therapy | Phase 2 | Lupus Nephritis | - | - |
Anti-CD20 mAB | Phase 2 | Multiple Sclerosis, Primary Progressive | - | - |
KYV101 | Phase 2 | Rheumatoid Arthritis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Kyverna Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Kyverna Therapeutics, Inc.'s (KYTX) pipeline across Phase 3, Phase 2. Its lead program is KYV-101 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Kyverna Therapeutics, Inc.'s next FDA catalyst?→
Kyverna Therapeutics, Inc.'s (KYTX) next tracked catalyst is a Phase 2 readout expected April 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track KYTX biotech catalysts?→
Add KYTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Kyverna Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
